What is amastigote form of Trypanosoma?
Trypanosoma cruzi, the causative agent of Chagas’ disease assumes two distinct forms in vertebrate hosts: circulating trypomastigote and tissular amastigote. This latter form infects predominantly the myocardium, smooth and skeletal muscle, and central nervous system.
What is the difference between trypomastigote and amastigote and?
Trypomastigotes invade cells, where they reproduce asexually as amastigotes. The cell dies and amastigotes are released. Some will infect other cells and continue the amastigote reproductive cycle, while others will circulate in the blood, where they develop into nondividing trypomastigotes.
What disease is caused by Trypanosoma cruzi?
What is Chagas disease? Chagas disease is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors and is found only in the Americas (mainly, in rural areas of Latin America where poverty is widespread).
What is meant by amastigote?
An amastigote is a protist cell that does not have visible external flagella or cilia. The term is used mainly to describe an intracellular phase in the life-cycle of trypanosomes that replicates.
What is amastigote and Promastigote?
Leishmania parasites are dimorphic organisms that live and replicate in the gut of sandflies as flagellated forms (promastigote) or as aflagellated forms (amastigotes) in mammalian cells. In the mammalian host these parasites preferentially infect phagocytic cells, primarily macrophages and dendritic cells.
What organs does Chagas disease affect?
What is Chagas disease? Chagas disease, or American trypanosomiasis, is an illness that can cause serious heart and stomach problems. It is caused by a parasite. Chagas disease is common in Latin America, especially in poor, rural areas.
Where is Trypanosoma cruzi found?
It is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors and is found only in the Americas (mainly, in rural areas of Latin America where poverty is widespread).
How is leishmaniasis treated in humans?
Liposomal amphotericin B is FDA-approved for treatment of visceral leishmaniasis and generally is the treatment of choice for U.S. patients.